The caregivers’ perspective on the end-of-life phase of glioblastoma patients

Birgit Flechl, Michael Ackerl, Cornelia Sax, +10

Journal of Neuro-Oncology

NursingPalliative CareNeuro-oncologyEnd-of-life CareMedicine +9

End of life care in high-grade glioma patients in three European countries: a comparative study

Johan A F Koekkoek, Linda Dirven, Jaap C. Reijneveld, +13

Journal of Neuro-Oncology

Palliative CareNeuro-oncologyHospiceEnd-of-life CareHigh-grade Glioma Patients +8

Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors

Birgit Flechl, Michael Ackerl, Cornelia Sax, +6

Journal of Neuro-Oncology

Neuro-oncologySociodemographic FunctioningNeuropsychologyBrain Tumor BiologyNeurology +6

Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO)

Annette Leibetseder, Michael Ackerl, Birgit Flechl, +8

Neuro-Oncology

The course of quality of life and neurocognition in newly diagnosed patients with glioblastoma

Birgit Flechl, Cornelia Sax, Michael Ackerl, +11

Radiotherapy and Oncology

Neuro-oncologyQuality Of LifeClinical NeurologyBrain Tumor BiologyNeuroscience +8

Response to imatinib as a function of target kinase expression in recurrent glioblastoma

Marco Hassler, Mariam Vedadinejad, Birgit Flechl, +8

SpringerPlus

Strength of skeletal muscle and self-reported physical performance in Austrian glioblastoma-patients

Mohammad Kéilani, Christoph Krall, Christine Marosi, +5

Wiener klinische Wochenschrift

Neuro-oncologyMuscle FunctionKinesiologyMuscle InjuryGlioma +12

Sorafenib for patients with pretreated recurrent or progressive high-grade glioma

Marco Hassler, Michael Ackerl, Birgit Flechl, +7

Anti-Cancer Drugs

Are hypothyroidism and hypogonadism clinically relevant in patients with malignant gliomas? A longitudinal trial in patients with glioma

Ammon Handisurya, Tamara Rumpold, Carola Caucig-Lütgendorf, +13

Radiotherapy and Oncology

Neuro-oncologyThyroid DiseaseNeuroendocrine DisorderGynecologyMalignant Gliomas +7

The Value of SSTR2 Receptor-Targeted PET/CT in Proton Irradiation of Grade I Meningioma

Maciej Pelak, Birgit Flechl, Marta Mumot, +4

Cancers